237 related articles for article (PubMed ID: 19585648)
41. Transbody against hepatitis B virus core protein inhibits hepatitis B virus replication in vitro.
Wang Y; Li Y; Li N; Zhu Q; Hui L; Liu X; Han Q; Lv Y; Wang Q; Yang G; Zhou Z; Liu Z
Int Immunopharmacol; 2015 Apr; 25(2):363-9. PubMed ID: 25676532
[TBL] [Abstract][Full Text] [Related]
42. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.
Ghezzi S; Galli L; Kajaste-Rudnitski A; Turrini F; Marelli S; Toniolo D; Casoli C; Riva A; Poli G; Castagna A; Vicenzi E
AIDS; 2013 Sep; 27(15):2335-44. PubMed ID: 23921607
[TBL] [Abstract][Full Text] [Related]
43. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
44. TRIM22 inhibits respiratory syncytial virus replication by targeting JAK-STAT1/2 signaling.
Wang Y; Chen Y; Lin Y; Quan Y; Xiao X; Zhang R
J Med Virol; 2021 Jun; 93(6):3412-3419. PubMed ID: 32803897
[TBL] [Abstract][Full Text] [Related]
45. Anti-viral effect of a compound isolated from Liriope platyphylla against hepatitis B virus in vitro.
Huang TJ; Tsai YC; Chiang SY; Wang GJ; Kuo YC; Chang YC; Wu YY; Wu YC
Virus Res; 2014 Nov; 192():16-24. PubMed ID: 25150190
[TBL] [Abstract][Full Text] [Related]
46. Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a pathway independent of the phosphorylation of the viral core protein.
Zheng Y; Fu XD; Ou JH
Virology; 2005 Nov; 342(1):150-8. PubMed ID: 16122776
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract][Full Text] [Related]
48. Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy.
Chung YL; Tsai TY
Mol Cancer Res; 2009 Oct; 7(10):1672-85. PubMed ID: 19808906
[TBL] [Abstract][Full Text] [Related]
49. [Expressions and co-localization of HIV capsid protein p24 and TRIM22 in HEK293T cells].
Sun D; An X; Zhou Y; Ji B; Song X; Xu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Aug; 31(8):1081-4. PubMed ID: 26271984
[TBL] [Abstract][Full Text] [Related]
50. Identification of TRIM22 as a progesterone-responsive gene in Ishikawa endometrial cancer cells.
Saito-Kanatani M; Urano T; Hiroi H; Momoeda M; Ito M; Fujii T; Inoue S
J Steroid Biochem Mol Biol; 2015 Nov; 154():217-25. PubMed ID: 26316153
[TBL] [Abstract][Full Text] [Related]
51. Interferons command Trim22 to fight against viruses.
Lian Q; Sun B
Cell Mol Immunol; 2017 Sep; 14(9):794-796. PubMed ID: 28782753
[No Abstract] [Full Text] [Related]
52. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus.
Delaney WE; Isom HC
Hepatology; 1998 Oct; 28(4):1134-46. PubMed ID: 9755254
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
[TBL] [Abstract][Full Text] [Related]
54. A new compound from Micromonospora sp. SA246, 9-hydroxycrisamicin-A, activates hepatitis B virus replication.
Yoon SW; Park IY; Sohn BH; Lee J; Yeo WH; Lee YI
Biochem Biophys Res Commun; 2004 Jul; 319(3):859-65. PubMed ID: 15184062
[TBL] [Abstract][Full Text] [Related]
55. Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow.
Obad S; Olofsson T; Mechti N; Gullberg U; Drott K
Leuk Res; 2007 Jul; 31(7):995-1001. PubMed ID: 17257675
[TBL] [Abstract][Full Text] [Related]
56. Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells.
Guo H; Jiang D; Ma D; Chang J; Dougherty AM; Cuconati A; Block TM; Guo JT
J Virol; 2009 Jan; 83(2):847-58. PubMed ID: 18971270
[TBL] [Abstract][Full Text] [Related]
57. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of Hepatitis B virus replication by phospholipid scramblase 1 in vitro and in vivo.
Yang J; Zhu X; Liu J; Ding X; Han M; Hu W; Wang X; Zhou Z; Wang S
Antiviral Res; 2012 Apr; 94(1):9-17. PubMed ID: 22342889
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis B virus replication in well differentiated mouse hepatocyte cell lines immortalized by plasmid DNA.
Chen SH; Hu CP; Chang CM
Cancer Res; 1992 Mar; 52(5):1329-35. PubMed ID: 1737394
[TBL] [Abstract][Full Text] [Related]
60. Requirement of the cyclic adenosine monophosphate response element-binding protein for hepatitis B virus replication.
Kim BK; Lim SO; Park YG
Hepatology; 2008 Aug; 48(2):361-73. PubMed ID: 18615500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
